CD8A and colorectal carcinoma: Versican (VCAN), a large matrix proteoglycan with immunoregulatory activity, has been reported to prevent the interaction between hyaluronan and T cells to inhibit adhesion and migration (33), and versican-derived matrikines regulate Batf3-dendritic cell differentiation and promote CD8+ T-cell infiltration in CRC (34).